125I-JR11

N/A

Report date: 2025/11/20 16:03:50

NME

Base Information

Drug Name125I-JR11

Drug Alias Name125I-JR11

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Iodine > 125I +[4]

Mechanisms of ActionSomatostatin receptor 2 binders

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Bern

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Bern

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A